Snipd home pageGet the app
public
Critical Care Reviews Podcast chevron_right

COMBAT-COVID Trial

Feb 28, 2022
27:17
forum Ask episode
view_agenda Chapters
auto_awesome Transcript
info_circle Episode notes
1
Introduction
00:00 • 1min
chevron_right
2
Prostocyclin and Endothelialopathy: A Phase 2 Trial
01:30 • 3min
chevron_right
3
Prostocyclin and the Role of Prostaglandins in Respiratory Failure
04:59 • 2min
chevron_right
4
The Role of Thrombo-Modulin in Anti-Pulmonary Edema Interventions
06:33 • 3min
chevron_right
5
Prostocycline's Anti-Plated Effect
09:50 • 2min
chevron_right
6
The Effects of Prostocycline on Vascular Barriers
11:27 • 3min
chevron_right
7
The Effects of the Process Cycling on Endothelial Integrity
14:32 • 2min
chevron_right
8
Prostate Cycling in Critical Illness
16:16 • 2min
chevron_right
9
Prostacycline and the ARDS Population
17:55 • 2min
chevron_right
10
The Cost to Cycling Intervention for Septic Shock and Severe Endothelialopathy
20:14 • 2min
chevron_right
11
Prostacyclin and Endociliopathy in the Critically Ill
22:00 • 3min
chevron_right

Pär Johansson from Copenhagen joins Rob Mac Sweeney to discuss the fascinating phase II COMBAT-COVID trial, investigating prostacyclin in intubated patients with COVID-19 and severe endotheliopathy. The trial was published in the American Journal of Respiratory and Critical Care Medicine in November 2021.

HomeTop podcastsPopular guests